These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 35635337)

  • 1. Pretargeted PET of Osteodestructive Lesions in Dogs.
    Maitz CA; Delaney S; Cook BE; Genady AR; Hoerres R; Kuchuk M; Makris G; Valliant JF; Sadeghi S; Lewis JS; Hennkens HM; Bryan JN; Zeglis BM
    Mol Pharm; 2022 Sep; 19(9):3153-3162. PubMed ID: 35635337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of a Pretargeted Strategy for the PET Imaging of Colorectal Carcinoma via the Modulation of Radioligand Pharmacokinetics.
    Zeglis BM; Brand C; Abdel-Atti D; Carnazza KE; Cook BE; Carlin S; Reiner T; Lewis JS
    Mol Pharm; 2015 Oct; 12(10):3575-87. PubMed ID: 26287993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual Radionuclide Theranostic Pretargeting.
    Keinänen O; Brennan JM; Membreno R; Fung K; Gangangari K; Dayts EJ; Williams CJ; Zeglis BM
    Mol Pharm; 2019 Oct; 16(10):4416-4421. PubMed ID: 31483993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the inverse electron demand Diels-Alder reaction in rats using a scandium-44-labelled tetrazine for pretargeted PET imaging.
    Edem PE; Sinnes JP; Pektor S; Bausbacher N; Rossin R; Yazdani A; Miederer M; Kjær A; Valliant JF; Robillard MS; Rösch F; Herth MM
    EJNMMI Res; 2019 May; 9(1):49. PubMed ID: 31140047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved stability of a novel fluorine-18 labeled TCO analogue for pretargeted PET imaging.
    Ruivo E; Adhikari K; Elvas F; Fissers J; Vangestel C; Staelens S; Stroobants S; Van der Veken P; Wyffels L; Augustyns K
    Nucl Med Biol; 2019; 76-77():36-42. PubMed ID: 31707309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inverse electron demand Diels-Alder click chemistry for pretargeted PET imaging and radioimmunotherapy.
    Sarrett SM; Keinänen O; Dayts EJ; Dewaele-Le Roi G; Rodriguez C; Carnazza KE; Zeglis BM
    Nat Protoc; 2021 Jul; 16(7):3348-3381. PubMed ID: 34127865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harnessing
    Keinänen O; Fung K; Brennan JM; Zia N; Harris M; van Dam E; Biggin C; Hedt A; Stoner J; Donnelly PS; Lewis JS; Zeglis BM
    Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28316-28327. PubMed ID: 33106429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Pretargeted Imaging Strategy for Immune Checkpoint Ligand PD-L1 Expression in Tumor Based on Bioorthogonal Diels-Alder Click Chemistry.
    Qiu L; Tan H; Lin Q; Si Z; Mao W; Wang T; Fu Z; Cheng D; Shi H
    Mol Imaging Biol; 2020 Aug; 22(4):842-853. PubMed ID: 31741201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretargeted PET Imaging Using a Site-Specifically Labeled Immunoconjugate.
    Cook BE; Adumeau P; Membreno R; Carnazza KE; Brand C; Reiner T; Agnew BJ; Lewis JS; Zeglis BM
    Bioconjug Chem; 2016 Aug; 27(8):1789-95. PubMed ID: 27356886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pretargeted PET imaging strategy based on bioorthogonal Diels-Alder click chemistry.
    Zeglis BM; Sevak KK; Reiner T; Mohindra P; Carlin SD; Zanzonico P; Weissleder R; Lewis JS
    J Nucl Med; 2013 Aug; 54(8):1389-96. PubMed ID: 23708196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (18)F-Based Pretargeted PET Imaging Based on Bioorthogonal Diels-Alder Click Chemistry.
    Meyer JP; Houghton JL; Kozlowski P; Abdel-Atti D; Reiner T; Pillarsetty NV; Scholz WW; Zeglis BM; Lewis JS
    Bioconjug Chem; 2016 Feb; 27(2):298-301. PubMed ID: 26479967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretargeted radioimmunotherapy and SPECT imaging of peritoneal carcinomatosis using bioorthogonal click chemistry: probe selection and first proof-of-concept.
    Rondon A; Schmitt S; Briat A; Ty N; Maigne L; Quintana M; Membreno R; Zeglis BM; Navarro-Teulon I; Pouget JP; Chezal JM; Miot-Noirault E; Moreau E; Degoul F
    Theranostics; 2019; 9(22):6706-6718. PubMed ID: 31588245
    [No Abstract]   [Full Text] [Related]  

  • 13. Click-Mediated Pretargeted Radioimmunotherapy of Colorectal Carcinoma.
    Membreno R; Cook BE; Fung K; Lewis JS; Zeglis BM
    Mol Pharm; 2018 Apr; 15(4):1729-1734. PubMed ID: 29502416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of the In Vivo Efficacy of Pretargeted Radioimmunotherapy Utilizing Inverse Electron Demand Diels-Alder Click Chemistry.
    Houghton JL; Membreno R; Abdel-Atti D; Cunanan KM; Carlin S; Scholz WW; Zanzonico PB; Lewis JS; Zeglis BM
    Mol Cancer Ther; 2017 Jan; 16(1):124-133. PubMed ID: 28062708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioorthogonal Diels-Alder Click Chemistry-Based Pretargeted PET Imaging Strategy for Monitoring Programmed Death-Ligand 1 Expression.
    Huang Y; Li Z; Li C; Zang Z; Wang Q; Huang S; Liu Q; Liang Y
    ACS Omega; 2024 Sep; 9(35):36969-36981. PubMed ID: 39246495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward the Optimization of Click-Mediated Pretargeted Radioimmunotherapy.
    Membreno R; Keinänen OM; Cook BE; Tully KM; Fung KC; Lewis JS; Zeglis BM
    Mol Pharm; 2019 May; 16(5):2259-2263. PubMed ID: 30912951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioorthogonal Masking of Circulating Antibody-TCO Groups Using Tetrazine-Functionalized Dextran Polymers.
    Meyer JP; Tully KM; Jackson J; Dilling TR; Reiner T; Lewis JS
    Bioconjug Chem; 2018 Feb; 29(2):538-545. PubMed ID: 29378403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretargeted Immuno-PET of Pancreatic Cancer: Overcoming Circulating Antigen and Internalized Antibody to Reduce Radiation Doses.
    Houghton JL; Zeglis BM; Abdel-Atti D; Sawada R; Scholz WW; Lewis JS
    J Nucl Med; 2016 Mar; 57(3):453-9. PubMed ID: 26471693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Efficient Method for Labeling Single Domain Antibody Fragments with
    Zhou Z; Devoogdt N; Zalutsky MR; Vaidyanathan G
    Bioconjug Chem; 2018 Dec; 29(12):4090-4103. PubMed ID: 30384599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-Based In Vivo Imaging of Central Nervous System Targets-Evaluation of a Pretargeting Approach Utilizing a TCO-Conjugated Brain Shuttle Antibody and Radiolabeled Tetrazines.
    Bredack C; Edelmann MR; Borroni E; Gobbi LC; Honer M
    Pharmaceuticals (Basel); 2022 Nov; 15(12):. PubMed ID: 36558900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.